Insulet reported a higher-than-expected profit in the fourth quarter on Thursday, driven by strong demand for its wearable insulin pumps.

Looking ahead, Insulet provided a strong outlook for 2025, projecting total revenue growth of 16% to 20% in constant currency. The company expects U.S. Omnipod revenue to grow 16% to 20% and ...

Baird last night initiated coverage of Beta Bionics (BBNX) with a Neutral rating and $20 price target The firm believes Beta’s iLet Bionic ...

By Phil Galewitz for KFF Health News. Broadcast version by Trimmel Gomes for Florida News Connection reporting for the KFF Health News-Public News Service Collaboration Just a few years ago, children ...

In an “urgent medical device correction,” the company urges clinicians to remind patients to monitor their glucose levels during takeoffs and landings.

From diet soda to zero-sugar ice cream, artificial sweeteners have been touted as a guilt-free way to indulge our sweet tooth ...

While the issue has fallen from the headlines after several moves to cap the cost, some patients with diabetes still often ...

FOX 2 - A 100-year-old vaccine is getting a fresh look as it's being studied to treat an autoimmune disease. One local child who's hoping to help change the world for people with type 1 diabetes.

Third-quarter results for Medtronic (NYSE:MDT) included a timeline for a planned label expansion for its automated insulin ...

An artificial pancreas combines a glucose monitor with an insulin pump. In this video, Griffin Rodgers, MD, director of ...

The FDA has approved the first rapid-acting biosimilar insulin product for glycemic control in people with diabetes. Merilog ...